Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non–small-cell lung cancer
A Aupérin, C Le Péchoux, E Rolland… - Journal of clinical …, 2010 - ascopubs.org
Purpose The previous individual patient data meta-analyses of chemotherapy in locally
advanced non–small-cell lung cancer (NSCLC) showed that adding sequential or …
advanced non–small-cell lung cancer (NSCLC) showed that adding sequential or …
Multidisciplinary management of lung cancer
Despite years of research, the five-year survival rate among patients with lung cancer is a
mere 14 percent. Lung cancer is divided into two major types—non–small-cell lung cancer …
mere 14 percent. Lung cancer is divided into two major types—non–small-cell lung cancer …
Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial
KS Albain, RS Swann, VW Rusch, AT Turrisi… - The Lancet, 2009 - thelancet.com
Background Results from phase II studies in patients with stage IIIA non-small-cell lung
cancer with ipsilateral mediastinal nodal metastases (N2) have shown the feasibility of …
cancer with ipsilateral mediastinal nodal metastases (N2) have shown the feasibility of …
Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non–small-cell lung cancer …
K Kelly, K Chansky, LE Gaspar, KS Albain… - Journal of clinical …, 2008 - ascopubs.org
Purpose Early clinical studies with gefitinib showed promising efficacy and mild toxicity in
patients with advanced non–small-cell lung cancer (NSCLC). Thus, gefitinib was an ideal …
patients with advanced non–small-cell lung cancer (NSCLC). Thus, gefitinib was an ideal …
Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non–small-cell lung …
N Hanna, M Neubauer, C Yiannoutsos… - Journal of clinical …, 2008 - ascopubs.org
Purpose Concurrent chemoradiotherapy is standard treatment for patients with inoperable
stage III non–small-cell lung cancer (NSCLC). A phase II study by the Southwest Oncology …
stage III non–small-cell lung cancer (NSCLC). A phase II study by the Southwest Oncology …
Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III non–small-cell lung …
Purpose Standard therapy for unresectable stage III non–small-cell lung cancer includes
concomitant chemoradiotherapy. In Cancer and Leukemia Group B 39801, we evaluated …
concomitant chemoradiotherapy. In Cancer and Leukemia Group B 39801, we evaluated …
Concurrent chemoradiotherapy in non‐small cell lung cancer
Background This is an updated version of the original review published in Issue 4, 2004.
The use of concurrent chemotherapy and radiotherapy in non‐small cell lung cancer …
The use of concurrent chemotherapy and radiotherapy in non‐small cell lung cancer …
Advances in radiotherapy and implications for the next century: a historical perspective
The use of ionizing radiation for the treatment of cancer dates back to the late 19th century,
remarkably soon after Roentgen described X-rays in 1895 and the use of brachytherapy …
remarkably soon after Roentgen described X-rays in 1895 and the use of brachytherapy …
Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non–small-cell lung cancer: Groupe …
P Fournel, G Robinet, P Thomas, PJ Souquet… - Journal of clinical …, 2005 - ascopubs.org
Purpose We conducted a phase III study to compare the survival impact of concurrent versus
sequential treatment with radiotherapy (RT) and chemotherapy (CT) in unresectable stage III …
sequential treatment with radiotherapy (RT) and chemotherapy (CT) in unresectable stage III …
Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non–small cell lung carcinoma treated with …
PURPOSE: Patients treated with chemoradiotherapy for locally advanced non–small-cell
lung carcinoma (LA-NSCLC) were analyzed for local-regional failure (LRF) and overall …
lung carcinoma (LA-NSCLC) were analyzed for local-regional failure (LRF) and overall …